Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis.
Overview
and 8 other authors
Nathan M Merrill5, Sofia Diana Merajver5, Qingyun Li11,12,13, Katherine Schwetye9,10, Vaibhav Jain2, Simon G Gregory2,14,15, Albert H Kim3,11,12,16, Ron Bose1,916 affiliations
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
- Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina
- Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri
- Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
- Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan
- Duke Center for Brain and Spine Metastasis, Duke University School of Medicine, Durham, North Carolina
- Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina
- Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
- Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri
- Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri
- The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina
- Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina
- The Brain Tumor Center, Washington University School of Medicine, St. Louis, Missouri
Abstract
Brain metastases occur in up to 40% of patients with stage IV breast cancer, and the cerebellum is a common site for metastases in HER2-positive breast cancer. We developed a syngeneic, immunocompetent mouse model of breast cancer brain metastases (BCBM) by stereotactically injecting murine breast cancer organoids into the cerebellum. Spatial transcriptomics on these brain metastases revealed that breast cancer cells produce interleukin-34 (IL34), which induces ARG1+ macrophages at the invading edge of metastases. IL34 expression in human brain metastasis samples was measured in two independent datasets, and IL34 was expressed widely in both HER2+ and HER2− human BCBM. Remarkably, IL34-deficient breast cancer cells failed to establish tumors in the mouse cerebellum. Furthermore, treatment with a blocking antibody against the IL34 receptor, CSF1R, led to tumor shrinkage, highlighting the translational potential of these findings, as a CSF1R-blocking antibody is FDA-approved for another indication, graft-versus-host disease.
Significance: Targeting IL34–CSF1R is a potential new approach to treat BCBM and could be combined with existing therapies. IL34 expression is widely found in human BCBM.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
codeocean:7986416
Availability: 1 check, the latest on 27 September 2026: cannot be verified
- 27 September 2026: cannot be verified
codeocean.com/widget.js
Availability: 20 checks, the latest on 8 October 2026: unreachable at the last attempt (HTTP 403)
- 8 October 2026: unreachable at the last attempt (HTTP 403)
- 8 October 2026: unreachable at the last attempt (HTTP 403)
- 8 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
- 6 October 2026: unreachable at the last attempt (HTTP 403)
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 2 repositories of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Datasets cited
- geo:GSE325996, at NCBI GEO; found in “Data Availability”
Data Availability
Spatial transcriptomics data generated in this study are deposited in the Gene Expression Omnibus, accession code GSE325996 (https://
https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 28 authors, 10 MeSH terms, 5 funders, 66 references, 21 RRIDs.
Cite
This paper
Cheng, X., Patel, K. K., Zhou, B., Fu, Y., Cleary, R. T., Highkin, M., Hsia, J., Jin, X., Kohn, B., Prior, J. L., Michie, M. S., Sun, R., Cheng, X., Bao, L., Heth, J., Rastogi, T., Van Swearingen, A. E., Quirk, J. D., Hagemann, I. S., . . . Bose, R. (2026). Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis. Cancer research communications, 6(6), 1388-1404. https://
BibTeX
@article{cheng2026interl
author = {Cheng, Xiaoqing and Patel, Khooshbu K and Zhou, Brandon and Fu, Yiwei and Cleary, Ryan T and Highkin, Maureen and Hsia, Jacob and Jin, Xiaohua and Kohn, Benjamin and Prior, Julie L and Michie, Megan S and Sun, Rui and Cheng, Xu and Bao, Liwei and Heth, Jason and Rastogi, Tusharika and Van Swearingen, Amanda ED and Quirk, James D and Hagemann, Ian S and Morikawa, Aki and Merrill, Nathan M and Merajver, Sofia Diana and Li, Qingyun and Schwetye, Katherine and Jain, Vaibhav and Gregory, Simon G and Kim, Albert H and Bose, Ron},
title = {{Interleukin-34-Induced
journal = {Cancer research communications},
year = {2026},
month = jun,
volume = {6},
number = {6},
pages = {1388--1404},
publisher = {American Association for Cancer Research},
issn = {2767-9764},
doi = {10.1158/
url = {https://
pmid = {42166785},
pmcid = {PMC13261624}
}
RIS
TY - JOUR
AU - Cheng, Xiaoqing
AU - Patel, Khooshbu K
AU - Zhou, Brandon
AU - Fu, Yiwei
AU - Cleary, Ryan T
AU - Highkin, Maureen
AU - Hsia, Jacob
AU - Jin, Xiaohua
AU - Kohn, Benjamin
AU - Prior, Julie L
AU - Michie, Megan S
AU - Sun, Rui
AU - Cheng, Xu
AU - Bao, Liwei
AU - Heth, Jason
AU - Rastogi, Tusharika
AU - Van Swearingen, Amanda ED
AU - Quirk, James D
AU - Hagemann, Ian S
AU - Morikawa, Aki
AU - Merrill, Nathan M
AU - Merajver, Sofia Diana
AU - Li, Qingyun
AU - Schwetye, Katherine
AU - Jain, Vaibhav
AU - Gregory, Simon G
AU - Kim, Albert H
AU - Bose, Ron
TI - Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis
T2 - Cancer research communications
J2 - Cancer Res Commun
PY - 2026
DA - 2026/
VL - 6
IS - 6
SP - 1388
EP - 1404
SN - 2767-9764
PB - American Association for Cancer Research
DO - 10.1158/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1158/
"type": "article-journal",
"title": "Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis",
"container-title": "Cancer research communications",
"author": [
{
"family": "Cheng",
"given": "Xiaoqing"
},
{
"family": "Patel",
"given": "Khooshbu K"
},
{
"family": "Zhou",
"given": "Brandon"
},
{
"family": "Fu",
"given": "Yiwei"
},
{
"family": "Cleary",
"given": "Ryan T"
},
{
"family": "Highkin",
"given": "Maureen"
},
{
"family": "Hsia",
"given": "Jacob"
},
{
"family": "Jin",
"given": "Xiaohua"
},
{
"family": "Kohn",
"given": "Benjamin"
},
{
"family": "Prior",
"given": "Julie L"
},
{
"family": "Michie",
"given": "Megan S"
},
{
"family": "Sun",
"given": "Rui"
},
{
"family": "Cheng",
"given": "Xu"
},
{
"family": "Bao",
"given": "Liwei"
},
{
"family": "Heth",
"given": "Jason"
},
{
"family": "Rastogi",
"given": "Tusharika"
},
{
"family": "Van Swearingen",
"given": "Amanda ED"
},
{
"family": "Quirk",
"given": "James D"
},
{
"family": "Hagemann",
"given": "Ian S"
},
{
"family": "Morikawa",
"given": "Aki"
},
{
"family": "Merrill",
"given": "Nathan M"
},
{
"family": "Merajver",
"given": "Sofia Diana"
},
{
"family": "Li",
"given": "Qingyun"
},
{
"family": "Schwetye",
"given": "Katherine"
},
{
"family": "Jain",
"given": "Vaibhav"
},
{
"family": "Gregory",
"given": "Simon G"
},
{
"family": "Kim",
"given": "Albert H"
},
{
"family": "Bose",
"given": "Ron"
}
],
"container-title-short":
"volume": "6",
"issue": "6",
"page": "1388-1404",
"DOI": "10.1158/
"PMID": "42166785",
"PMCID": "PMC13261624",
"ISSN": "2767-9764",
"publisher": "American Association for Cancer Research",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
1
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1093/neuonc/noag080
- Laser interstitial thermal therapy enhances bidirectional blood-brain barrier permeability in glioblastoma.Journal: Neuro-oncologyIn common: other condition, mouse, 2 authors
- [2] doi:10.1073/pnas.2420793122
- Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: other condition, mouse, 4 references
- [3] doi:10.1038/s41419-026-08807-w [code]
- Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.Journal: Cell death & diseaseIn common: other condition, mouse, 5 references
- [4] doi:10.1186/s40478-025-02001-3 [code]
- Genomic and immune profiling of breast cancer brain metastases.Journal: Acta neuropathologica communicationsIn common: other condition, 1 reference, author Amanda ED Van Swearingen
- [5] doi:10.1172/jci170329
- PI3K/
mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. Journal: The Journal of clinical investigationIn common: other condition, mouse, author Simon G Gregory - [6] doi:10.1038/s41467-022-34879-1 [code]
- Spatially aware dimension reduction for spatial transcriptomics.Journal: Nature communicationsIn common: other condition, 5 references
- [7] doi:10.1038/s41467-023-38121-4 [code]
- Reconstruction of the cell pseudo-space from single-cell RNA sequencing data with scSpace.Journal: Nature communicationsIn common: other condition, 5 references
- [8] doi:10.1038/s41467-025-66371-x
- INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model.Journal: Nature communicationsIn common: other condition, mouse, author Albert H Kim
- [9] doi:10.1007/s10585-026-10449-3
- Mapping intratumoral coverage of neural stem cell-delivered anti-HER2 antibody in breast cancer brain metastasis.Journal: Clinical & experimental metastasisIn common: other condition, mouse, 3 references
- [10] doi:10.1186/s40478-025-02035-7 [code]
- A comprehensive, multi-center, immunogenomic analysis of melanoma brain metastases.Journal: Acta neuropathologica communicationsIn common: other condition, author Amanda ED Van Swearingen
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 2 repositories of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:cb13ef569b1c68f9…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1158/2767-9764.crc-25-0639)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1158/2767-9764.crc-25-0639.svg
:target: https://openscicode.org/badge/doi/10.1158/2767-9764.crc-25-0639
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1158/2767-9764.crc-25-0639"><img src="https://openscicode.org/badge/doi/10.1158/2767-9764.crc-25-0639.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
